CVE-2020-12036Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (P…
Updated under an hour ago ()
Does this affect you?
It affects baxter prismaflex_firmware and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.50%, higher than 41% of scored CVEs.
Do this next
Free account, 1 product
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.
- CVSS
- 7.5 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- Weakness (CWE)
- CWE-319
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.50% (percentile 41)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Aug 4, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
baxter prismaflex_firmware baxter:prismaflex_firmware | all versions | NVD |
baxter prismax_firmware baxter:prismax_firmware | before 3.0 | NVD |
References
- https://www.us-cert.gov/ics/advisories/icsma-20-170-01x-refsource-misc, not-applicable
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.